2 Followers on Owler

Attune

Pharmaceuticals develops novel orally-administered small-molecule therapies for the treatment of genetic disorders... Read more
OverviewCompetitorsFundingNews & Insights

Attune

Pharmaceuticals develops novel orally-administered small-molecule therapies for the treatment of genetic disorders... Read more
Attune Co-Founder & CEO: Andrew McDonald

Co-Founder & CEO

Andrew McDonald

CEO Approval Rating

89/100

2018

PrivateIndependent Company

Pharmaceuticals & Biotechnology
BiotechnologyMedical Research & Laboratories
28368731 NAICS listing

Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
25-100
Agree?
Funding
$23M

Attune Competitors

1Corvus
2Madrigal
3NexImmune
4Altor BioScience
5Dermira
6Intercept
7Gilead
8Suneva Medical
9Galectin
10Galmed Pharmaceuticals
Unlock 12 + competitors

Trending Companies